Evidence map›Paper›PMID 23703970›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2013

Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma.

Scott M Langevin, Dominique S Michaud, Carmen J Marsit, Heather H Nelson, Ariel E Birnbaum, Melissa Eliot, Brock C Christensen, Michael D McClean, Karl T Kelsey

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Exercise benefits meet the esophagus.Journal of sport and health science · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Evaluation of Voice After Definitive Radiotherapy in Patients of Early Stage Squamous Cell Carcinoma of Larynx (Glottis): A Prospective Observational Study.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Pepsin and Laryngeal and Hypopharyngeal Carcinomas.Clinical and experimental otorhinolaryngology · 2021
    Review
  15. Article
  16. Article
  17. Periodontal Conditions and Whole Salivary IL-17A and -23 Levels among Young AdultInternational journal of environmental research and public health · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Scott M LangevinDepartment of Epidemiology, Brown University, Providence, RI 02912, USA.
Dominique S Michaud
Carmen J Marsit
Heather H Nelson
Ariel E Birnbaum
Melissa Eliot
Brock C Christensen
Michael D McClean
Karl T Kelsey
Boston University · USBrown University · USMasonic Cancer CenterUniversity of Minnesota · USDartmouth Psychiatric Research Center · US

Funding

TRAINING IN ENVIRONMENTAL PATHOLOGYT32ES007272 · NIEHS · BROWN UNIVERSITY · PI ZHITKOVICH, ANATOLY · 1992 to 2021
$7.5M
The Boston Collaborative Oral Cancer StudyR01CA078609 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1999 to 2010
$5.3M
Patterns of Somatic Gene Alterations in Oral CancerR01CA100679 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 2004 to 2012
$2.6M
The Molecular Epidemiology of Bladder CancerR01CA121147 · NCI · BROWN UNIVERSITY · PI KELSEY, KARL TIMOTHY · 2007 to 2010
$2.0M
NCI NIH HHS R01 CA078609NCI NIH HHS R01CA078609NCI NIH HHS R01 CA100679NCI NIH HHS R01CA100679NCI NIH HHS R01 CA121147NCI NIH HHS R01CA121147NIEHS NIH HHS T32 ES007272NIEHS NIH HHS T32ES07272
6 · The paper itself

Abstract

backgroundGastric reflux can reach into the upper airway, inducing cellular damage in the epithelial lining. This condition is believed to be a risk factor for development of laryngopharyngeal squamous cell carcinoma (LPSCC), although the literature is conflicting.

methodsTo better clarify this relationship, we assessed the association of self-reported heartburn history and medication use among 631 patients with LPSCCs and 1234 control subjects (frequency-matched on age, gender, and town of residence) enrolled as part of a population-based case-control study of head and neck squamous cell carcinoma in the greater Boston area.

resultsAfter adjusting for age, gender, race, smoking, alcohol consumption, HPV16 seropositivity, education, and body mass index, subjects reporting a history of frequent heartburn and who were neither a heavy smoker nor heavy drinker had a significantly elevated risk of LPSCCs [OR, 1.78; 95% confidence interval (CI), 1.00-3.16]. Among those with a history of heartburn, there was an inverse association between antacid use and LPSCCs relative to those never taking heartburn medication (OR, 0.59; 95% CI, 0.38-0.93) that remained consistent when analyzed by smoking/drinking status, HPV16 status, or by primary tumor site.

conclusionsOur data show that gastric reflux is an independent risk factor for squamous cancers of the pharynx and larynx. Further studies are needed to clarify the possible chemopreventive role of antacid use for patients with gastric reflux. IMPACT: Elucidation of additional risk factors for head and neck cancer can allow for risk stratification and inform surveillance of high-risk patients.

Indexed as

Carcinoma, Squamous CellCase-Control StudiesFemaleFollow-Up StudiesGastroesophageal RefluxHumansLaryngeal NeoplasmsMaleMiddle AgedPharyngeal NeoplasmsPrognosisRisk Factors

Identifiers

PMID23703970
PMCPMC3681904
OpenAlexW2171218301

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.